ロード中...
Development and validation of a chemiluminescent immunodetection assay amenable to High Throughput Screening of antiviral drugs for Nipah and Hendra Virus
There are currently no antiviral drugs approved for the highly lethal Biosafety Level Four pathogens Nipah and Hendra virus. A number of researchers are developing surrogate assays amenable to Biosafety Level Two biocontainment but ultimately, the development of a High Throughput Screening method fo...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2653211/ https://ncbi.nlm.nih.gov/pubmed/18313148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jviromet.2008.01.016 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|